News

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
So-called ‘skinny jabs’ are being prescribed to people who don’t need them, with terrifying side effects. How did our ...
Regarding injection site rotation, alternate between different areas like the abdomen, thigh, or upper arm to prevent ...
A woman offered services such as Botox injections, Ozempic shots, and body piercings without a proper license, according to Laredo police.
A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...
TikTok is loading up on fibre in Gen Z's latest food trend, fibermaxxing, which has a rare seal of approval from ...
The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.
Semaglutide (Ozempic) improves blood sugar control and weight loss in people with type 1 diabetes and obesity using insulin pumps, new study shows.
New research suggests, Ozempic might now support heart health, decreasing the likelihood of cardiac events even without type-2 diabetes. Doctor shares insights on the topic.
A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.
The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.